Arabic Arabic English English French French German German
dark

Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World’s First and Only Smart Knee Implant

Zimmer Biomet Holdings, Inc., a global medical technology leader, and Canary Medical, a medical data company, announced U.S. Food and Drug Administration De Novo classification grant and authorization to market the tibial extension for Persona IQ®, the world’s first and only smart knee cleared by the FDA for total knee replacement surgery. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

XPhyto Launches First Commercial Biosensor for Oral Disease

Next Post

CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA Therapeutic

Related Posts
Total
0
Share